MeiraGTx Holdings plc Stock Issued
MeiraGTx Holdings plc (MGTX) reported Stock Issued of $249.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2026-08-13
- MeiraGTx Holdings plc stock issued for the quarter ending 2026-06-30 was $0.00.
- MeiraGTx Holdings plc stock issued for the quarter ending 2026-03-31 was $249.00K.
- MeiraGTx Holdings plc stock issued for the quarter ending 2020-12-31 was $0.00.
- MeiraGTx Holdings plc stock issued for the quarter ending 2020-09-30 was $0.00.
- MeiraGTx Holdings plc stock issued for fiscal 2021 was $519.00K, a 93.25% decline from fiscal 2020.
- MeiraGTx Holdings plc stock issued for fiscal 2020 was $7.68M, a 1723.25% increase from fiscal 2019.
- MeiraGTx Holdings plc stock issued for fiscal 2019 was $421.50K, a 68.92% decline from fiscal 2018.
- MeiraGTx Holdings plc stock issued for fiscal 2018 was $1.36M.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 6 month as first filed | Stock Issued 9 month | Stock Issued 9 month as first filed | Stock Issued 12 month | Stock Issued 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $249.00K 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | $249.00K 10-Q · filed 2026-05-14 | ||||||
| 2021-12-31 | $519.00K 10-K · filed 2022-03-10 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $7.68M 10-K · filed 2022-03-10 | $7.69M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.68M 10-Q · filed 2021-11-10 | $7.69M 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $7.68M 10-Q · filed 2021-08-11 | $7.69M 10-Q · filed 2020-08-06 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $421.50K 10-K · filed 2021-03-11 | |||||
| 2019-09-30 | $421.50K 10-Q · filed 2020-11-05 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $1.36M 10-K · filed 2020-03-11 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $1.36M 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.36M 10-Q · filed 2019-08-07 | |||||
| 2018-03-31 | $1.36M 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |